WASHINGTON, Aug 31 (Reuters) - U.S. drug reviewers questioned whether Novartis AG's experimental inhaled antibiotic powder truly helped cystic fibrosis patients breathe better, according to documents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results